Why 2026 may be a strong year for biotech stocks
Biotech stocks have staged an impressive rally over the past six months, with the XBI index – key benchmark for small and mid-cap biotech names – posting one of its strongest stretches on record. Mizuho’s senior healthcare analyst Jared Holz believes this momentum is more than a short-term bounce. Speaking with CNBC, he argued the
